Adverse events40,618

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 40,618Pages stop at row 10,000

Type	Event	Organ system	Group	Affected	At risk
other	Fatigue	General disorders	Dose Escalation Cohort: Avelumab 1.0 mg/kg	2	4
other	Fatigue	General disorders	Dose Escalation Cohort: Avelumab 3.0 mg/kg	7	13
other	Fatigue	General disorders	Dose Escalation Cohort: Avelumab 10.0 mg/kg	13	15
other	Fatigue	General disorders	Dose Escalation Cohort: Avelumab 20.0 mg/kg	6	21
other	Fatigue	General disorders	Dose Escalation Cohort: Avelumab 10.0 mg/kg Weekly	3	8
other	Fatigue	General disorders	Primary Expansion Cohort: NSCLC, Post-platinum Doublet	74	184
other	Fatigue	General disorders	Primary Expansion Cohort: NSCLC, First Line	71	156
other	Fatigue	General disorders	Primary Expansion Cohort: Metastatic Breast Cancer	66	168
other	Fatigue	General disorders	Primary Expansion Cohort: GC/GEJC Progressed	13	60
other	Fatigue	General disorders	Primary Expansion Cohort: GC/GEJC Non Progressed	20	90
other	Fatigue	General disorders	Secondary Expansion Cohort: Colorectal Cancer	5	21
other	Fatigue	General disorders	Secondary Expansion Cohort: Castrate-resistant Prostate Cancer	7	18
other	Fatigue	General disorders	Secondary Expansion Cohort: Adrenocortical Carcinoma	17	50
other	Fatigue	General disorders	Secondary Expansion Cohort: Melanoma	13	51
other	Fatigue	General disorders	Secondary Expansion Cohort: Mesothelioma	17	53
other	Fatigue	General disorders	Secondary Expansion Cohort: Urothelial Carcinoma	17	44
other	Fatigue	General disorders	Secondary Expansion Cohort: Ovarian Cancer	36	125
other	Fatigue	General disorders	Secondary Expansion Cohort: Renal Cell Carcinoma (First Line)	27	62
other	Fatigue	General disorders	Secondary Expansion Cohort: Renal Cell Carcinoma (Second Line)	10	20
other	Fatigue	General disorders	Efficacy Expansion Cohort: Ovarian Cancer	38	103

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01772004/events

API reference For AI assistants

Adverse events40,618

Sources 3

Read this list from software.